A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects

NCT07014488 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: HRS-5041 Tablets
DRUG: Rifampicin Capsule

Sponsor

Jiangsu HengRui Medicine Co., Ltd.